…disability (TE: -15; 95% CI: -18.3 to -11.7), and sciatica (TE: -3.2; 95% CI: -4.3 to -2.1) with S at 1 y; operative complications include dural tears (4% of…
Read More…1 studies demonstrating decreased adjacent segment degeneration, minimal component wear issues, and lower revision rates than fusion. Rationale A common definition of an experimental technique is one that is…
Read More…US I 344 coflex Direct decompres- sion via laminecto- my w/ subsequent implantation coflex ILS OR Decompres- sion via laminecto- my w/ subsequent posterolateral instru- mented fusion Age coflex:…
Read More…icon-camera https://www.isass.org/event_galleries/2015-04-isass15-posters/ zoomIn flat_box 1/3 https://www.isass.org/event_galleries/2015-04-isass15-cadaver-lab/slides/DSC_4112.JPG ISASS15 – Cadaver Lab Saturday, April 18, 2015. icon-camera https://www.isass.org/event_galleries/2015-04-isass15-cadaver-lab/ zoomIn flat_box 1/3…
Read More…Examiners’ Prize for Best Overall Results in the M.Ch(Orth) examination) 1991 French Academic Exchange Programme -Training in Spine Surgery in France under Dr Daniel Chopin at Institut Calot, Berck-Plage…
Read More…consists of three components: upper and lower plates composed of cobalt-chrome molybdenium alloy (CoCrMo) and a monoconvex ultra-high molecular-weight polyethylene inlay.69 Combined, these components form a spherical articulating device…
Read More…is like the nephew of Evidence-Based Medicine. President Obama started his term by allocating 1.1 billion dollars for comparative effectiveness research. The main feature of comparative effectiveness research is…
Read More…2006. This device consists of three components: upper and lower plates composed of cobalt-chrome molybdenium alloy (CoCrMo) and a monoconvex ultra-high molecular-weight polyethylene inlay.69 Combined, these components form a…
Read More…111%-119%) greater life expectancy than patients treated conservatively. On the other hand, vertebroplasty has a 44% (P < .001; 95% CI: 42%-47%) increase compared with conservatively treated patients. Direct…
Read More…pure DDD from randomized comparative trials on arthroplasty. First, the Pro-Disc FDA IDE trial has just published the two-year outcomes on 2-level circumferential fusion patients. This study is a…
Read More…tissue products. Further, in 2001, the first Class III medical device grafting material was approved by the FDA, bone morphogenetic protein (BMP)-2. In the mid- 2000s, annual sales of B…
Read More…The North American Spine Society, and the Scoliosis Research Society. Many of these societies have honored Dr. Yuan’s research and writing with grants and research awards. He has authored…
Read More